Release Time:2019-10-24 |
Hits:
Yingjie Zhang
+
Gender:Male
Education Level:Postgraduate (Doctoral)
Alma Mater:山东大学
Paper Publications
Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Institution:药学院
Title of Paper:Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Journal:Anti-cancer agents in medicinal chemistry
First Author:高帅
All the Authors:徐文方,Yingjie Zhang
Document Code:D23360BF099544ED984837D788DD749A
Volume:17
Issue:6
Page Number:802
Translation or Not:No
Date of Publication:2017-06